There are 24 resources available
The Search for Biomarkers in Bladder Cancer
Presenter: J. Bellmunt, ES
Session: SESSION 1 Personalised Therapy in BC and RCC
Resources:
Immunotherapy
Presenter: J. Bellmunt, ES
Session: SESSION 6 Side Effects
Resources:
Tyrosine Kinase Inhibitors and mTOR Inhibitors
Presenter: N. Vasudev, UK
Session: SESSION 6 Side Effects
Resources:
Chemotherapy
Presenter: R. Kanesvaran, SG
Session: SESSION 6 Side Effects
Resources:
Participant Clinical Case Discussion: Metastatic Papillary Renal Cell Carcinoma
Presenter: J. Y.-Y. Khoo, MY
Session: SESSION 6 Side Effects
Resources:
Clinical Application
Presenter: C. K. Toh, SG
Session: SESSION 5 Pathology and Molecular Pathology
Resources:
Participant Clinical Case Discussion: Unusual Response of Urothelial Carcinoma to Immunotherapy
Presenter: S. C. Saldanha, IN
Session: SESSION 4 Debate of the Day
Resources:
Participant Clinical Case Discussion: Renal Cell Carcinoma (Sarcomatoid Variant) with Bone Metastasis
Presenter: A. Sreevatsa, IN
Session: SESSION 4 Debate of the Day
Resources:
Systemic Chemotherapy is the Standard for Metastatic Urothelial Cancer: NO
Presenter: J. Bellmunt, ES
Session: SESSION 4 Debate of the Day
Resources:
Systemic Chemotherapy is the Standard for Metastatic Urothelial Cancer: YES
Presenter: C. K. Toh, SG
Session: SESSION 4 Debate of the Day
Resources: